Author
Listed:
- N. Alexia Raharinirina
(Freie Universität Berlin)
- Nils Gubela
(Freie Universität Berlin
Max-Planck Institute for Molecular Genetics)
- Daniela Börnigen
(Robert Koch Institute)
- Maureen Rebecca Smith
(Robert Koch Institute)
- Djin-Ye Oh
(Robert Koch Institute)
- Matthias Budt
(Robert Koch Institute)
- Christin Mache
(Robert Koch Institute)
- Claudia Schillings
(Freie Universität Berlin)
- Stephan Fuchs
(Robert Koch Institute)
- Ralf Dürrwald
(Robert Koch Institute)
- Thorsten Wolff
(Robert Koch Institute)
- Martin Hölzer
(Robert Koch Institute)
- Sofia Paraskevopoulou
(Robert Koch Institute)
- Max Kleist
(Freie Universität Berlin
Robert Koch Institute)
Abstract
Since the onset of the pandemic, many SARS-CoV-2 variants have emerged, exhibiting substantial evolution in the virus’ spike protein1, the main target of neutralizing antibodies2. A plausible hypothesis proposes that the virus evolves to evade antibody-mediated neutralization (vaccine- or infection-induced) to maximize its ability to infect an immunologically experienced population1,3. Because viral infection induces neutralizing antibodies, viral evolution may thus navigate on a dynamic immune landscape that is shaped by local infection history. Here we developed a comprehensive mechanistic model, incorporating deep mutational scanning data4,5, antibody pharmacokinetics and regional genomic surveillance data, to predict the variant-specific relative number of susceptible individuals over time. We show that this quantity precisely matched historical variant dynamics, predicted future variant dynamics and explained global differences in variant dynamics. Our work strongly suggests that the ongoing pandemic continues to shape variant-specific population immunity, which determines a variant’s ability to transmit, thus defining variant fitness. The model can be applied to any region by utilizing local genomic surveillance data, allows contextualizing risk assessment of variants and provides information for vaccine design.
Suggested Citation
N. Alexia Raharinirina & Nils Gubela & Daniela Börnigen & Maureen Rebecca Smith & Djin-Ye Oh & Matthias Budt & Christin Mache & Claudia Schillings & Stephan Fuchs & Ralf Dürrwald & Thorsten Wolff & Ma, 2025.
"SARS-CoV-2 evolution on a dynamic immune landscape,"
Nature, Nature, vol. 639(8053), pages 196-204, March.
Handle:
RePEc:nat:nature:v:639:y:2025:i:8053:d:10.1038_s41586-024-08477-8
DOI: 10.1038/s41586-024-08477-8
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:639:y:2025:i:8053:d:10.1038_s41586-024-08477-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.